ZA993975B - Combination therapy for musculoskeletal frailty. - Google Patents

Combination therapy for musculoskeletal frailty.

Info

Publication number
ZA993975B
ZA993975B ZA9903975A ZA993975A ZA993975B ZA 993975 B ZA993975 B ZA 993975B ZA 9903975 A ZA9903975 A ZA 9903975A ZA 993975 A ZA993975 A ZA 993975A ZA 993975 B ZA993975 B ZA 993975B
Authority
ZA
South Africa
Prior art keywords
combination therapy
musculoskeletal frailty
frailty
musculoskeletal
therapy
Prior art date
Application number
ZA9903975A
Inventor
Hua Zhu Ke
Mei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA993975B publication Critical patent/ZA993975B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA9903975A 1998-06-16 1999-06-15 Combination therapy for musculoskeletal frailty. ZA993975B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
ZA993975B true ZA993975B (en) 2000-12-15

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9903975A ZA993975B (en) 1998-06-16 1999-06-15 Combination therapy for musculoskeletal frailty.

Country Status (30)

Country Link
EP (1) EP1087764A1 (en)
JP (1) JP2002518326A (en)
KR (1) KR20010052852A (en)
CN (1) CN1301160A (en)
AP (1) AP9901582A0 (en)
AR (1) AR018869A1 (en)
AU (1) AU4054799A (en)
BG (1) BG105041A (en)
BR (1) BR9911324A (en)
CA (1) CA2335134A1 (en)
CO (1) CO5070587A1 (en)
EA (1) EA200001186A1 (en)
GT (1) GT199900087A (en)
HN (1) HN1999000097A (en)
HR (1) HRP20000859A2 (en)
HU (1) HUP0102505A3 (en)
ID (1) ID27599A (en)
IL (1) IL138630A0 (en)
IS (1) IS5691A (en)
MA (1) MA26652A1 (en)
NO (1) NO20006312D0 (en)
OA (1) OA11505A (en)
PA (1) PA8475901A1 (en)
PE (1) PE20000646A1 (en)
PL (1) PL344981A1 (en)
SK (1) SK18912000A3 (en)
TN (1) TNSN99124A1 (en)
TR (1) TR200003544T2 (en)
WO (1) WO1999065486A1 (en)
ZA (1) ZA993975B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2653300A (en) * 1999-02-08 2000-08-29 Mcgill University Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
EP1156120B1 (en) 2000-05-08 2006-11-22 Pfizer Products Inc. Enzymatic resolution of selective estrogen receptor modulators
BR0113626A (en) * 2000-08-30 2003-06-17 Pfizer Prod Inc Sustained-Release Formulations for Growth Hormone Secretors
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
BRPI0807046A2 (en) 2007-02-09 2015-05-26 Tranzyme Pharma Inc Compound, pharmaceutical composition, methods of treating a disorder, cardiovascular disease and a patient suffering from reduced or dysfunctional gastrointestinal motility and, kit.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (en) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS

Also Published As

Publication number Publication date
CA2335134A1 (en) 1999-12-23
TNSN99124A1 (en) 2005-11-10
ID27599A (en) 2001-04-12
BG105041A (en) 2001-08-31
SK18912000A3 (en) 2001-10-08
CO5070587A1 (en) 2001-08-28
PE20000646A1 (en) 2000-08-05
AU4054799A (en) 2000-01-05
AR018869A1 (en) 2001-12-12
GT199900087A (en) 2000-12-07
NO20006312L (en) 2000-12-12
HUP0102505A2 (en) 2001-11-28
IL138630A0 (en) 2001-10-31
CN1301160A (en) 2001-06-27
EP1087764A1 (en) 2001-04-04
IS5691A (en) 2000-10-27
HN1999000097A (en) 1999-11-03
JP2002518326A (en) 2002-06-25
HRP20000859A2 (en) 2001-04-30
KR20010052852A (en) 2001-06-25
PL344981A1 (en) 2001-11-19
PA8475901A1 (en) 2000-05-24
BR9911324A (en) 2001-04-03
TR200003544T2 (en) 2001-04-20
WO1999065486A1 (en) 1999-12-23
HUP0102505A3 (en) 2002-12-28
MA26652A1 (en) 2004-12-20
NO20006312D0 (en) 2000-12-12
EA200001186A1 (en) 2001-06-25
OA11505A (en) 2004-05-07
AP9901582A0 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
ZA987839B (en) Combination therapy.
GB9817118D0 (en) Pharmaceutical compounds
ZA200108000B (en) Cosmetic compounds.
EP1089751A4 (en) Adjuvant therapy
GB9817623D0 (en) Pharmaceutical compounds
GB9804885D0 (en) Therapeutic combination
ZA987843B (en) Combination therapy.
GB9810886D0 (en) Pharmaceutical compounds
TW524114U (en) Massager
GB9812038D0 (en) Therapeutic compound
ZA973209B (en) Therapeutic compounds.
GB9816556D0 (en) Therapy
ZA993975B (en) Combination therapy for musculoskeletal frailty.
ZA993973B (en) Therapeutic combinations for musculoskeletal frailty.
GB9823847D0 (en) Pharmaceutical compounds
GB9808665D0 (en) Therapeutic compounds
GB9823845D0 (en) Pharmaceutical compounds
GB9824897D0 (en) Therapeutic compounds
GB9817197D0 (en) Pharmaceutical compounds
TW404250U (en) Massage machine
GB9827865D0 (en) Medicament
GB9808667D0 (en) Therapeutic compounds
TW365168U (en) Massage machine
GB9806039D0 (en) Therapy
HK1032349A1 (en) Melanoma therapy.